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O B J E C T I V E S This study sought to compare the direct cost of medical care and clinical events
during the ﬁrst year after patients with intermediate risk acute chest pain were randomized to stress
cardiac magnetic resonance (CMR) observation unit (OU) testing versus inpatient care.
B A C KG ROUND In a recent study, randomization to OU-CMR reduced median index hospitaliza-
tion cost compared with the cost of inpatient care in patients presenting to the emergency department
with intermediate risk acute chest pain.
METHOD S Emergency department patients with intermediate risk chest pain were randomized to
OU-CMR (OU care, cardiacmarkers, stress CMR) or inpatient care (admission, care per admitting provider). This
analysis reports the direct cost of cardiac-related care and clinical outcomes (myocardial infarction,
revascularization, cardiovascular death) during the ﬁrst year of follow-up subsequent to discharge. Consistent
with health economics literature, provider cost was calculated fromwork-related relative value units using the
Medicare conversion factor; facility charges were converted to cost using departmental-speciﬁc cost-to-
charge ratios. Linear models were used to compare cost accumulation among study groups.
R E S U L T S We included 109 randomized subjects in this analysis (52 OU-CMR, 57 inpatient care). The median
agewas 56 years; baseline characteristicswere similar in both groups. At 1 year, 6%ofOU-CMRand9%of inpatient
care participants experienced amajor cardiac event (p 0.72) with 1 patient in each group experiencing a cardiac
event after discharge. First-year cardiac-related costs were signiﬁcantly lower for participants randomized to
OU-CMR than for participants receiving inpatient care (geometric mean  $3,101 vs. $4,742 including the index
visit [p 0.004] and $29 vs. $152 following discharge [p 0.012]). During the year following randomization, 6%
of OU-CMR and 9% of inpatient care participants experienced a major cardiac event (p  0.72).
CONC L U S I O N S An OU-CMR strategy reduces cardiac-related costs of medical care during the
index visit and over the ﬁrst year subsequent to discharge, without an observed increase in major cardiac
events. (Cost Comparison of Cardiac Magnetic Resonance Imaging [MRI] Use in Emergency Department
[ED] Patients With Chest Pain; NCT00678639) (J Am Coll Cardiol Img 2011;4:862–70) © 2011 by the
American College of Cardiology Foundation
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863hest pain observation units reduce costs of
the index hospital visits for patients with
chest pain (1,2) and are recommended for
use in the American College of Cardiolo-
y/American Heart Association (ACC/AHA)
uidelines (3). However, patients with intermediate
isk chest pain and no definite evidence for acute
oronary syndrome (ACS) are commonly admitted
or inpatient care due to the difficulty of managing
atients with prior coronary heart events, and the
igher acuity of their presenting illness.
A recent randomized clinical trial in emergency
epartment (ED) patients with intermediate risk chest
ain demonstrated that observation unit (OU) care
oupled with stress cardiac magnetic resonance testing
CMR) was associated with a median reduction in
ost of $588 during the index hospitalization when
ompared the costs of inpatient hospital care (4).
owever, the cost of an index hospitalization may not
dequately reflect resource consumption for a particu-
ar illness; also, the care delivered during the index
ospitalization may influence downstream care patterns.
The objective of this study was to compare the
ost of medical care, measures of resource utiliza-
ion, and report the clinical outcomes in ED pa-
ients with intermediate risk acute chest pain in the
ear following randomization to either inpatient
are or OU-CMR. We anticipated that the reduc-
ion in index hospital visit cost seen with OU-CMR
ould be followed by similar utilization patterns
mong groups after hospital discharge. We sus-
ected that reductions seen with OU-CMR would
ccur without an increase in the rates of major
ardiac events.
M E T H O D S
Study design. As previously described (4), we con-
ucted a single-center randomized clinical trial. All
articipants provided written informed consent.
he study was approved by the Institutional Review
North Carolina. Dr. Hwang is now affiliated with the Division of Heal
Sciences, Penn State Hershey College of Medicine, Hershey, Pennsylv
Translational Science Institute of Wake Forest University School of M
HL097131-01A1 [to Dr. Miller] and 1 R01 HL076438 [to Dr. Hundley
[to Dr. Miller]). Dr. Miller has received research grants from EKR T
Corporation, and Novartis Pharmaceuticals; research support from Siemen
of Wade E. Byrd, P.A., and Lewis and Oliver. Dr. Hoekstra has received
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at ACC.11/i2 Summit in New Orleans in April 2011.Manuscript received December 20, 2010; revised manuscript received Marchoard of Wake Forest University School of Medi-
ine and complied with the Health Insurance Por-
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From January 2008 through April 2009, par-
icipants were recruited from the ED of a tertiary
are referral center that has an annual volume of
6,000 visits per year and is a level 1 trauma
enter. The ED is staffed by board-prepared/
oard-certified emergency physicians supervising
are provided by residents in training. The ob-
ervation unit is under the direction of the ED
nd is staffed by nurse practitioners and physician
ssistants with care provided jointly with emer-
ency physicians. Cardiovascular medicine con-
ultation is available at the discretion of the
mergency physicians.
We enrolled individuals presenting to the ED with
ntermediate risk acute chest pain. Intermediate risk
as defined as at least an intermediate prob-
bility that the patient’s symptoms were
elated to ACS or a TIMI (Thrombolysis In
yocardial Infarction) risk score 2 calcu-
ated in the ED. Care providers were en-
ouraged to use the ACC/AHA framework
o formulate their clinical impression. Addi-
ional inclusion criteria were age 18 years,
are provider impression that an inpatient
ssessment was indicated, and care provider
ssessment that the patient could be dis-
harged if cardiac disease was excluded. Ex-
lusion criteria were an initial troponin I
evel above the diagnostic threshold for
yocardial infarction (MI), ST-segment el-
vation (1 mV) or depression (2 mV),
ontraindications to CMR, systolic
lood pressure 90 mm Hg, inability to
ie flat, refusal of follow-up procedures, 3
onths life expectancy, pregnancy, renal insuffi-
iency (such that the estimated glomerular filtra-
ion rate was 45 ml/min), chronic liver disease,
r solid organ transplant.
ervices Research, Department of Public Health
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864To find eligible participants, the study staff
screened ED patients with chest pain or related
symptoms from 8 AM to 11 PM Monday through
hursday and 8 AM to 11 AM on Friday. Consented
participants were then randomized to 1 of 2 study
arms: OU-CMR or inpatient care. OU-CMR par-
ticipants were placed into the OU, received serial
cardiac markers at 4 and 8 h from the initial marker,
and had orders placed for a stress CMR study. One
OU-CMR participant left against medical advice
prior to OU placement. Inpatient care participants
were consulted for admission following standard
admission practices at the study institution. Study
patients were admitted to the services of cardiolo-
gists (n  29), internists (n  17), family medicine
physicians (n  8), with 3 leaving against medical
advice prior to admission.
OU-CMR imaging protocol. Imaging in OU-CMR
articipants has been previously described (4) and
as similar to imaging used for clinical care at the
tudy institution. In general, imaging was con-
ucted with a 1.5-T Siemens Magnetom Avanto
ystem (Siemens Medical Solutions, Munich, Ger-
any). Initial orders were placed for an adenosine
MR, which included the imaging sequences noted
n Table 1. Dobutamine stress was available as an
lternative in the event adenosine was contraindi-
ated. Images were interpreted by board-certified
ardiology or radiology faculty with at least level II
raining in CMR (5).
Outcomes and deﬁnitions. The primary outcome of
his analysis is the direct cost of cardiac-related
ealth care through 1 year after randomization.
tilization measures used to calculate cost were
ardiac-related hospital admissions, cardiac proce-
ures, and cardiac-related office visits, further de-
ned in Table 2. If a hospitalization or office visit
ing Sequences for OU-CMR Participants
Views
Pulse
Sequence
Imaging
Matrix (
2-, 3-, and 4-chamber and
3 LV short-axis views
Cine SSFP 192 156
il) 2-, 3-, and 4-chamber and
3 LV short-axis views
IR turbo-SE
(2 RR, no FS)
256 162
t and Stress Agent Injection Gadopentetate Dimeglumine (0.1 m
3 LV short-axis views Turbo-GRE 192 108 3
Contrast Injection Gadopentetate Dimeg
3 LV short-axis views Turbo-GRE 192 108 3
2-, 3-, and 4-chamber and
10 LV short-axis views
IR GRE 300 TI 192 140 3
resonance imaging; FOV  ﬁeld of view; FS  fat saturation; GRE  gradient ech
spin echo; SSFP  steady-state free precession; TE  echo time; TI  inversion timet the definition of cardiac-related, the entire cost
f the visit was considered cardiac-related. The
econdary outcome is major cardiac events, com-
osed of MI, revascularization, and cardiovascular
eath.
Myocardial infarction occurring at the study
nstitution was defined as a troponin I 1.0 ng/ml
n the presence of ischemic symptoms. Troponin I
as measured in the central lab using either the
nI-Ultra assay using the ADVIA Centaur plat-
orm (Siemens) or the Access AccuTnI Troponin I
ssay using the dxi800s platform (Beckman
oulter, Brea, California). Patients reporting major
ardiac events outside the study institution were
onsidered to have had the event.
Data collection and outcome measurement. After
andomization, patients were followed during their
ndex hospitalization by record review. Study staff
hen conducted a structured record review and
elephone follow-up at approximately 30 days, 3
onths, 6 months, and 1 year after randomization.
articipants reporting hospitalizations occurring at
nother facility that were possibly cardiac-related
ad those records requested from the facility and
eviewed.
During each telephone follow-up, a modified
ersion of a previously described script was used to
dentify potential cardiac events (6). Participants
ere then asked to identify all healthcare encoun-
ers during the follow-up interval, which were then
ategorized as an office visit, an ED visit, a hospi-
alization, or a procedure. These patient reports
ere cross-referenced to those found in the medical
ecord at the time of the phone contact. After
ompletion of follow-up, itemized physician and
acility billing records were obtained for each par-
icipant for the year following enrollment. Billing
)
Slice
Thickness (mm)
TE
(ms)
TR
(ms)
Flip Angle
(°)
Bandwidth
(Hz/pix)
7 1.2 40 80 930
8 74 658 60/200 150
/kg) and Stress Agent: Adenosine or Dobutamine
8 1.1 170 12 650
ine (0.1 mmol/kg)
8 1.1 170 12 650
8 3.3 800 25 130
 inversion recovery; LV  left ventricle; OU  observation unit;Table 1. Typical Imag
Scan
FOV
mm
Resting wall motion 360
T2 dark blood (body co 360
Contras mol
Stress perfusion 60
lum
Rest perfusion 60
Delayed enhancement 20
CMR  cardiac magnetic o; IR
e; TR  repetition time.
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865information was then manually paired with the
encounters previously identified by record review
and telephone follow-up. Encounters discovered
through any of the 3 methods of identifying utili-
zation (phone, medical record review, and billing
record review) and classified as cardiac-related (Ta-
ble 2) were included in the primary analysis. When
available, exact dates were used for each component
of resource consumption. If the date was not avail-
able, the date between the last contact and event
reporting was used.
Follow-up was conducted with medical record
and billing record review on all participants through
1 year. In addition, telephone attempts continued
through the patient’s enrollment in the study re-
gardless of the success of the prior attempt.
Follow-up time was included through 1 year for
those patients with more than 1 year of follow-up.
For those patients who could not be contacted at 1
year, we used data through the longer of either the
last telephone contact or when telephone and med-
ical records (including billing records) no longer dem-
onstrated accumulation of cardiac-related services.
Cost comprised 2 elements: provider and facility
cost. Provider cost was calculated by obtaining
work-related relative value units associated with
each charge and converting to dollars using the
Medicare conversion factor. Facility cost was
determined by applying to each charge the
departmental-specific cost to charge ratios used
to file cost reports with Centers for Medicare and
Medicaid Services annually. Costs for events
occurring at other institutions (8 of 246 events)
were calculated using the mean cost for similar
services consumed among other study partici-
pants at the study institution.
The sample size for this study was determined
to provide adequate power for assessing the effect
of OU-CMR on the cost of the index hospital
visit, which was the primary objective of this trial
(4). A cost model was constructed to assist in
estimating the possible treatment effect and the
variance of the index cost was estimated from
pilot data. Based on this information, it was
calculated that 110 participants would provide
90% power to detect a $2,000 difference in the
index hospital visit cost between study groups,
allowing for an 8% attrition rate.
Data analysis. Baseline demographics and clinical
utcomes were compared using Fisher exact tests
or proportions; medians of continuous variables
ere compared using Wilcoxon rank sum tests. The
rimary analysis compared the first-year cardiac-elated costs for patients randomized to OU-CMR
ith those costs for patients randomized to usual
npatient care. A year was defined as the first 360
ays following discharge, allowing us to look at
osts accrued over 12 equal “months” of 30 days.
inear regression was used to assess group differ-
nces in total costs and costs following discharge,
nadjusted and adjusted for patient characteristics.
ovariates included the 2 stratification variables
known coronary disease [Yes/No] and time of day
f presentation [6 AM to 3 PM or 3 PM to 6 AM]), age
at enrollment, sex, confirmed prior heart failure,
confirmed prior MI, confirmed prior coronary re-
vascularization, and chest pain at ED arrival. The
cost data were highly skewed so log transforma-
tions were used to reduce the skewness and to
stabilize the variances between groups. A small
constant of 1 was added to follow-up costs so that
log transformations could be used when the costs
were 0. The p values for group differences in cost
are based on analyses of the log-transformed data.
We then divided costs up into 12 monthly
periods of 30 days and repeated measures models
Table 2. Deﬁnition of Cardiac-Related Healthcare Utilization
Cardiac-related ED visits
Signs or symptoms of chest pain or dyspnea associated with eith
an ECG and cardiac markers being performed; or
discharge or admitting diagnosis related to cardiac disease (if
Cardiac-related hospitalizations
One of the following cardiac procedures performed:
Cardiac imaging/stress testing (excluding resting echo as a sol
Revascularization
Pacemaker/deﬁbrillator placement
Primary reason for admission is concern for ACS
Discharge diagnosis related to chest pain, MI, ACS, heart failure,
other cardiac disease
Cardiac-related outpatient visits
Cardiology appointment
Appointment associated with or leading to cardiac testing or pro
(imaging, catheterization, or revascularization)
Follow-up related to an ED visit for chest pain, a hospitalization f
or other cardiac hospitalization
Appointment due to chest pain
Appointment related to diagnosis or treatment of heart disease;
follow-up or visits with the primary care physician to follow
cardiac condition
Outpatient cardiac-related procedures
Cardiac imaging/stress testing
Cardiac rhythm monitoring (e.g., Holter monitor)
Revascularization
Pacemaker/deﬁbrillator placement
ACS  acute coronary syndrome; ECG  electrocardiogram; ED  emergency
MI  myocardial infarction.er:
provided)
e test)
or
cedure
or chest pain,
except routine
a stable
department;were used to assess changes over time and to
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866determine if the changes over time varied
by group. An unstructured covariance matrix was
used to account for the within-patient correlation
in costs over time.
R E S U L T S
Study population, study intervention, and follow-
up. Enrollment was conducted over 15 months
during which 180 patients appearing to meet inclu-
sion and exclusion criteria were approached to
consent for participation in the study. Twenty-five
exhibited unrecognized exclusion criteria, and 46
refused to participate in the randomization process.
The remaining 109 formed the study population
accounting for 110 participant encounters. One
participant was enrolled twice and the second
encounter was excluded from this analysis, al-
though the costs of the second encounter are
included along with the costs associated with the
initial counter for that participant. This analysis
included 57 participants randomized to inpatient
care and 52 randomized to OU-CMR. The
baseline characteristics of study participants are
shown in Table 3 and are not statistically differ-
ent between groups.
Of the 52 OU-CMR participants, 51 were man-
aged in the OU and 1 left against medical advice.
Stress CMR testing was conducted in 48 of 52
participants over a median scan time of 53 min.
Hospital admission was avoided in 41 OU-CMR
participants. In the inpatient care group, 3 of 57 left
aseline Characteristics of the Study Population
Inpatient Care
n  57
OU-CMR
n  52 p Value
edian (Q1, Q3) 57 (47, 64) 55 (48, 62) 0.54
30 (53) 24 (46) 0.57
40 (70) 35 (67) 0.84
ion 43 (75) 35 (67) 0.40
ellitus 23 (40)* 19 (37) 0.32
oking 18 (32) 18 (35) 0.84
emia 44 (77) 38 (73)* 0.66
failure 3 (5) 2 (4) 1.00
CAD 16 (29) 11 (21) 0.51
15 (26) 8 (15) 0.24
15 (26) 7 (13) 0.15
3 (5) 2 (4) 1.00
resented as n (%). Categorical variables compared with Fisher exact tests, and
pared with Wilcoxon rank sum test. *One participant with unknown diabetes
participants with unknown hyperlipidemia status were considered to not have
ions.
ronary artery bypass graft; CAD  coronary artery disease; PCI  percutaneous
ervention; Q1  ﬁrst quartile; Q3  third quartile; other abbreviations as in
2.against medical advice prior to admission and the iremaining 54 were admitted. Once admitted, 9
inpatient participants received stress CMR as part
of their clinical evaluation, 31 received stress echo-
cardiography, 9 received cardiac catheterization,
and 10 received no stress testing or catheterization.
Several patients in both groups received multiple
procedures.
All patients were followed through 360 days
using medical record review and billing record
analysis. Follow-up information after discharge was
obtained in 98% of participants through review of
medical and billing records, and phone interviews
designed to identify or confirm the absence of
events. Phone contact at 1 year or beyond was
established in 81%, each of whom contributed
360 days of information. Remaining participants
contributed follow-up data up to the last date of
known consumption of cardiac-related services or
the last date of phone follow-up. The mean
follow-up time was 320.5 days for the inpatient
care participants and 309.0 for the OU-CMR
participants.
Cardiac-related healthcare utilization. After discharge
from the index hospital visit, 15% of OU-CMR
participants experienced at least 1 cardiac-related
ED visit during the subsequent year compared with
37% in the inpatient care group (p  0.02) (Table 4).
Similarly, cardiac-related hospital admissions were
significantly lower in the OU-CMR group (12%)
compared with 35% in the inpatient care group
(p  0.01). No differences were seen in the number
f cardiac-related outpatient visits per group (p 
.30) with 83% of participants having between 0
nd 2 visits over the year.
Cardiac testing procedures by study group are
isplayed in Table 4. During the index visit, cardiac
atheterizations were performed in 13% of the
U-CMR group compared with 16% of the inpa-
ient care group (p  0.79). After discharge, no
ifference in the rates of stress testing were detected
OU-CMR 10% vs. inpatient care 16%, p  0.40),
ut the inpatient care group had a higher rate of
ardiac catheterization (19% vs. 2%) in the OU-
MR group (p  0.01). During the incident visit
nd the subsequent 1-year follow-up, more OU-
MR participants received stress testing (96% vs.
9%, p  0.01), whereas fewer received cardiac
atheterization (15% vs. 33%, p  0.04).
Clinical outcomes. From randomization to comple-
ion of follow-up, 8 participants experienced 9
ajor cardiac events. In the OU-CMR group, 2
articipants had major cardiac events during theTable 3. B
Age, yrs, m
Male sex
Caucasian
Hypertens
Diabetes m
Current sm
Hyperlipid
Prior heart
Established
Prior MI
Prior PCI
Prior CABG
Values are p
medians com
status and 2
these condit
CABG  co
coronary intndex visit: 1 experienced an MI before CMR
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867testing and had a percutaneous coronary interven-
tion (PCI) and 1 had inducible ischemia on CMR
testing and received coronary artery bypass graft
surgery. At follow-up, 1 additional patient had MI
without revascularization. In the inpatient group, 5
participants had major cardiac events during the
index hospitalization; all had PCI, 1 had MI. At
follow-up, 1 of these patients had an additional
PCI. There were no statistical differences among
groups in the occurrence of major cardiac events.
Cardiac-related healthcare costs. The distributions of
ost by study group from enrollment through 1 year
re shown in Figure 1, the cumulative accrual of
ost after discharge is shown in Figure 2, and the
ata are summarized in Table 5. Costs were re-
arkably variable, with overall costs ranging from
616 to $34,084 and follow-up costs ranging from
0 to $17,698. Considering all cardiac-related costs
rom enrollment through 360 days, the geometric
ean (95% confidence interval) cost was $3,101
$2,519 to $3,817) among OU-CMR participants
nd $4,742 ($3,888 to $5,783) among inpatient
are participants (p  0.004). The difference re-
Table 4. Cardiac-Related Healthcare Utilization and Clinical Eve
Index Visit
Inpatient Care O
Stress testing 40 (70)
Cardiac catheterization 9 (16)
Cardiac catheterization or stress testing 47 (82)
Cardiac-related ED visits NA
0
1
2
Cardiac-related hospital admissions NA
0
1
2
Outpatient cardiac-related visits NA
0
1–2
3–4
5
Major cardiac events† 5 (9)
Cardiovascular death 0 (0)
MI 1 (2)
Coronary revascularization 5 (9)
PCI 5 (9)
CABG 0 (0)
Values are presented as n (%). *Comparison between OU-CMR and inpatient ca
experiencing each event. Some participants experienced more than 1 event.
NA  not available; other abbreviations as in Tables 1, 2, and 3.ains significant once adjustment is made forovariates (p  0.018). In the adjusted model, prior
oronary artery disease (p  0.047), prior heart
failure (p  0.049), no prior revascularization (p 
0.029), and pain at ED arrival (p  0.046) were
associated with higher costs. When only consider-
ing the cost of care after discharge from the index
hospital visit, the geometric mean cost was $29 ($11
to $74) for OU-CMR participants and $152 ($63
to $366) among inpatient care participants (p 
0.012). This difference remains significant after
adjustment is made for covariates (p  0.049). In
he adjusted model, only pain at ED arrival (p 
.024) was associated with higher costs.
We then looked at the cardiac-related costs
ver time in both groups. The repeated measures
nalysis of covariance models showed a signifi-
ant time (p  0.001) and group (p  0.012)
effect with the costs for first month being signif-
icantly higher than for the other months and the
average costs for the inpatient group being higher
than for the OU-CMR group. Although it ap-
pears that the biggest difference between the 2
groups occurs in the first few months following
After Discharge Through 1
Year Follow-Up Period Cumulative
MR Inpatient Care OU-CMR Inpatient Care OU
96) 9 (16) 5 (10) 45 (79) 5
13) 11 (19) 1 (2) 19 (33)
98) 18 (32) 6 (12) 53 (93) 5
NA NA
36 (63) 4
14 (25)
7 (12)
NA NA
37 (65) 4
15 (26)
5 (9)
NA NA
19 (33) 2
26 (46) 2
9 (16)
3 (5)
4) 1 (2) 1 (2) 5 (9)
0) 0 (0) 0 (0) 0 (0)
2) 0 (0) 1 (2) 1 (2)
4) 1 (2) 0 (0) 5 (9)
2) 1 (2) 0 (0) 5 (9)
2) 0 (0) 0 (0) 0 (0)
r cumulative events was conducted with Fisher exact tests. †Values represents thnts
U-C -CMR p Value*
50 ( 0 (96) 0.01
7 ( 8 (15) 0.04
51 ( 1 (98) 0.37
NA 0.02
4 (85)
7 (13)
1 (2)
NA 0.01
6 (88)
5 (10)
1 (2)
NA 0.30
4 (46)
1 (40)
7 (13)
0 (0)
2 ( 3 (6) 0.72
0 ( 0 (0) —
1 ( 2 (4) 0.60
2 ( 2 (4) 0.44
1 ( 1 (2) 0.21
1 ( 1 (2) 0.48
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868nonsignificant (p  0.388). The only covariate
hat was significantly associated with higher cost
n this model was having prior heart failure (p 
0.001).
Cardiac-Related Cost From Randomization Through 1 Year
shows the cumulative distribution of cost by study group over 1
btained by calculating the percentage of patients with total cost
the index visit and follow-up cost) less than or equal to the cost
n the x-axis. In the observation unit cardiac magnetic resonance
group, 79% had total costs less than $5,000 compared to 58% of
nt care group, suggesting OU-CMR is a cost-reducing care
Cost Accumulation by Month Following Discharge Among
ups, Excluding the Index Hospital Visit Cost
ulative cost by study group after hospital discharge (y-axis) is dis-
month of follow-up (x-axis). Mean cumulative cost for a month is
as the sum of the costs across all patients up to and including
h divided by the number of patients. Observation unit cardiac
esonance (OU-CMR) participants had lower cost of care in the
discharge from the index hospital visit (p  0.012). Reduced cost
sult of fewer cardiac-related emergency department visits and
ated hospitalizations, suggesting that an OU-CMR strategy inﬂu-
utilization after discharge.D I S C U S S I O N
The results of this study indicate that a CMR
imaging strategy can be used in an OU to reduce
the cost of care for patients typically managed in the
inpatient setting. The reduction in costs seen with
OU-CMR during the index visit was not associated
with a “rebound” increase in consumption after
discharge, as would be seen if testing or interven-
tions were being deferred from the index visit. In
contrast, the OU-CMR group continued to accu-
mulate costs at a lower rate, due to fewer cardiac-
related ED visits, hospitalizations, and catheteriza-
tions. In this study, 1-year costs are lower in those
randomized to OU-CMR versus an inpatient ad-
mission at the time of their presentation to the ED.
Importance of considering care after hospital dis-
charge. Within the 1-year period after the original
D visit, one can detect health-related expenditures
hat may be deferred from the index visit to the
utpatient arena, account for changes in behavior
esulting from the care pathway, and assess differ-
nces in clinical outcomes. This has particular
mportance in cardiac care as a previous study (7)
as shown that PCIs are associated with an increase
n subsequent care utilization. Our results suggest
hat OU-CMR reduces follow-up costs. The source
f reduced cost relates to procedures and recidivism.
oth groups had similar patterns of cardiac-related
utpatient visits. However, the inpatient care group
xperienced higher rates of cardiac-related ED
isits, rehospitalizations, and cardiac catheteriza-
ions. Nearly one-third of the inpatient care group
eceived a cardiac catheterization by the trial’s end,
ompared with only 15% of the OU-CMR group.
hese findings are consistent with those reported
y Farkouh et al. (1) who also reported a reduction
n cardiac-related utilization associated with OU
are through 6 months of follow-up.
Observation unit care in patients with non–low risk
chest pain. OU care is common for patients with
chest pain, but is mostly used in patients with low
pre-test probability for ACS. OU care is not com-
monly implemented in patients with non–low risk
chest pain and the utility of OU care in this
population is not well understood. Only 1 other
trial (1) included patients with prior coronary events
and randomized patients to OU care versus inpa-
tient care. That trial by Farkouh et al. (1) allowed a
variety of testing modalities in the OU group,
including exercise electrocardiogram testing, stress
echo, and stress nuclear imaging. They found thatFigure 1.
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869months was dependent on using stress electrocar-
diogram testing without imaging; among the pa-
tients receiving stress imaging, there was no cost
benefit to OU care (8). Our findings contradict
their findings in that we demonstrated cost savings
with OU-CMR care through the first year after
presentation. This could mean that the cost reduc-
tion results from using stress CMR rather than OU
care, or perhaps it is the combination of using
CMR as an imaging modality within an OU that is
lowering 1-year follow-up costs.
Despite a class I endorsement by the ACC/AHA
guidelines (3), the safety of OU care is not well
investigated in patients with non–low risk chest
pain. In the OU arm of the trial by Farkouh et al.
(1), 3 of 214 patients from the OU group died
within 6 months of randomization, but 0 died in
the inpatient group (p  NS). The OU group also
xperienced a total of 6 cardiac events between 30
ays and 6 months from randomization compared
ith 1 in the inpatient group (p NS). In our trial,
patient in each group had a major cardiac event,
oth between 6 months and 1 year following
andomization. For OU-CMR participants, this is
onsistent with previous analyses demonstrating the
xcellent long-term prognosis after a negative stress
MR (9,10). The low event rates support our
nderlying assertion that an OU-CMR pathway
hould have similar safety to inpatient care because
oth pathways typically incorporate serial cardiac
arkers and objective cardiac testing. However, a
arger trial should address the safety of OU care in
his population.
Mechanisms for OU-CMR reducing cost. We propose
everal mechanisms that could, in part, contribute
o the observed differences in costs between the
reatment pathways. First, patients in the OU-
MR group could have been more stringently
elected for revascularization during the index visit.
s a result, the increase in post-revascularization
ardiac-related care occurred less often. Second,
atients in the OU-CMR group may have felt more
eassured, reducing their likelihood of returning to
Table 5. Cardiac-Related Costs Overall and Just During the Foll
Type of
Cost
Inpatient Care
n GM Median Min Q1 Q3 Ma
Overall† 57 4,742 3,850 616 2,669 9,710 26,6
Follow-up 57 152 187 0 32 3,777 17,6
*Unadjusted p value from t test on log-transformed data; adjusted p value fro
GM  geometric mean; Max maximum; Min  minimum; other abbreviatiohe ED. Similarly, a recent CMR exam could have wnfluenced physician behavior after discharge when
eciding whether to pursue a patient’s complaint of
hest pain. This mechanism could also potentially
ccount for the dramatic difference in catheteriza-
ions after discharge. Finally, it could be that
npatient care participants established relationships
ith subspecialists that in turn increased the likeli-
ood that a subspecialist procedure would be
erformed.
Rationale for CMR use in observation unit care. CMR
as felt by this study team to be the ideal imaging
odality for OU implementation. The strength
f CMR rests in its ability to provide a compre-
ensive evaluation without ionizing radiation.
he comprehensive assessment in this protocol
ncluded a T2-weighted assessment for myocar-
dial edema that often accompanies ACS, resting
left ventricular wall motion, resting and stress
perfusion to identify ischemia, and delayed en-
hancement to identify infarcts. Through this
comprehensive assessment, clinicians are readily
able to distinguish new infarcts or ischemia in the
setting of pre-existing infarcts, left ventricular
dilation, or hypertrophy. In addition, other
causes of chest pain, such as myocarditis, or other
processes that simulate infarcts (e.g., Takotsubo
cardiomyopathy) can be readily identified.
Study limitations. Our study has some limitations.
irst, the data were collected from a single center
nd contained a modest number of participants.
uture work will require a larger sample size from
ther sites to determine if these findings remain
alid across healthcare systems and diverse patient
opulations. Second, the results were obtained in
he tightly controlled setting of a clinical trial. The
U-CMR intervention may have a different effect
hen examined outside the clinical trial context.
hird, the classification of healthcare encounters as
ardiac-related or not cardiac-related was con-
ucted without the immediate knowledge of sub-
ects’ study group assignments. However, the study
roup assignment could have been obtained, as this
tep required a record review. Objective definitions
p Period
OU-CMR
n GM Median Min Q1 Q3 Max Un-a
52 3,101 2,186 1,020 1,957 4,308 34,084 0
50 29 32 0 0 559 11,637 0
gression analysis of log data. †Overall includes index visit and follow-up charges
in Tables 1 and 3.ow-U
p Value*
x djusted Adjusted
10 .004 0.018
98 .012 0.049
m re .ere used to standardize these assessments and
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870minimize bias; however, this represents a potential
threat to internal validity. Fourth, extensive medical
and financial record reviews were performed to
identify events after discharge, and further, most
patients were contacted at 1 year to identify addi-
tional events. However, some participants did not
contribute complete information. Follow-up did
not differ by group and we feel it is unlikely that this
introduced systematic error. Finally, there is the
possibility that patient groups were unbalanced
despite randomization. We stratified the random-
ization scheme based on prior coronary disease to
prevent this from occurring, no statistical differ-
ences in baseline data were seen among study
groups, and the findings remained significant after
adjusting for covariates in our cost models. How-
ever, we cannot entirely exclude the possibility that
differences in study groups contributed to ourdial Infarction). J Am Coll Cardiol
2007;50:e1–157.
All-cause readmiss
vascularization afterC O N C L U S I O N S
Early findings demonstrate that an OU-CMR
strategy is an efficient management strategy for ED
patients with intermediate risk chest pain, but
without definite ACS. In addition to reducing the
index hospital visit cost, an OU-CMR strategy
continues to reduce cost after hospital discharge
leading to lower total cost at 1 year compared with
inpatient care. The reduction in cost after discharge
was the result of fewer cardiac catheterizations,
cardiac-related ED visits, and cardiac-related hos-
pitalizations.
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